Statin safety: myths and reality
More frequent statin prescription, to achieve lower target low-density lipoprotein levels, as well as statin dose increase, is associated with inevitable raise in adverse event rates. The article compares statin benefits and the risk of adverse liver, muscle, brain, and kidney effects.
Saved in:
Main Authors: | Zh. D. Kobalava, S. V. Villevalde, E. K. Shavarova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2007-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1212 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statin treatment: myths and reality
by: L. A. Malay, et al.
Published: (2008-06-01) -
Statins associated diabetes: state of the problem in 2018
by: Zh. D. Kobalava, et al.
Published: (2018-09-01) -
Analysis of Safety Issues of Using Statins in Patients with Diabetes and Hypothyroidism
by: V. V. Arkhipov, et al.
Published: (2019-12-01) -
Statins: Evidence for effectiveness
by: K. Outhoff
Published: (2014-09-01) -
Statins and the risk of cataract
by: E. K. Butina, et al.
Published: (2019-12-01)